122
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Pseudomonas aeruginosa infection increases the readmission rate of COPD patients

, , , , , , & show all
Pages 3077-3083 | Published online: 02 Oct 2018

References

  • VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryRespirology201722357560128150362
  • BurchetteJECampbellGDGeraciSAPreventing Hospitalizations From Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseAm J Med Sci20173531314028104101
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
  • OgawaKKishiKEtiological and exacerbation factors for COPD. Air pollutionNihon Rinsho201674574374627254939
  • MackayAJHurstJRCOPD exacerbations: causes, prevention, and treatmentImmunol Allergy Clin North Am20133319511523337067
  • Garcia-VidalCAlmagroPRomaníVPseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective studyEur Respir J20093451072107819386694
  • FerrerMIoanasMArancibiaFMarcoMAde la BellacasaJPTorresAMicrobial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary diseaseCrit Care Med20053392003200916148472
  • GotoTFaridiMKCamargoCAJrHasegawaKTime-varying Readmission Diagnoses During 30 Days After Hospitalization for COPD ExacerbationMed Care201856867367829912841
  • BishwakarmaRZhangWKuoYFSharmaGLong-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPDInt J Chron Obstruct Pulmon Dis20171247748628203071
  • PauwelsRCalverleyPBuistASCOPD exacerbations: the importance of a standard definitionRespir Med20049829910714971871
  • HarriesTHThorntonHCrichtonSSchofieldPGilkesAWhitePTHospital readmissions for COPD: a retrospective longitudinal studyNPJ Prim Care Respir Med20172713128450741
  • EchevarriaCSteerJHeslop-MarshallKThe PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPDThorax201772868669328235886
  • SinghGZhangWKuoYFSharmaGAssociation of Psychological Disorders With 30-Day Readmission Rates in Patients With COPDChest2016149490591526204260
  • JeongSHLeeHCarriereKCComorbidity as a contributor to frequent severe acute exacerbation in COPD patientsInt J Chron Obstruct Pulmon Dis2016111857186527536097
  • GellatlySLHancockREPseudomonas aeruginosa: new insights into pathogenesis and host defensesPathog Dis201367315917323620179
  • PooleKMultidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organismsJ Mol Microbiol Biotechnol20013225526411321581
  • MoradaliMFGhodsSRehmBHPseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and PersistenceFront Cell Infect Microbiol201773928261568
  • GonzálezJEKeshavanNDMessing with bacterial quorum sensingMicrobiol Mol Biol Rev200670485987517158701
  • KuangZHaoYWallingBEJeffriesJLOhmanDELauGWPseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-APLoS One2011611e2709122069491
  • BerubeBJRangelSMHauserARPseudomonas aeruginosa: breaking down barriersCurr Genet201662110911326407972
  • SethiSEvansNGrantBJMurphyTFNew strains of bacteria and exacerbations of chronic obstructive pulmonary diseaseN Engl J Med2002347746547112181400
  • MiravitllesMEspinosaCFernández-LasoEMartosJAMaldonadoJAGallegoMRelationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPDChest19991161404610424501
  • NiYShiGYuYHaoJChenTSongHClinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysisInt J Chron Obstruct Pulmon Dis2015101465147526251586
  • ParkHShinJWParkSGKimWMicrobial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary diseasePLoS One2014910e10971025329665
  • DaiMYQiaoJPXuYHFeiGHRespiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestInt J Chron Obstruct Pulmon Dis2015102257226326527871
  • MurphyTFThe many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary diseaseClin Infect Dis200847121534153619025364
  • BoutouAKRasteYReidJAlshafiKPolkeyMIHopkinsonNSDoes a single Pseudomonas aeruginosa isolation predict COPD mortality?Eur Respir J201444379479725034565
  • AlmagroPSalvadóMGarcia-VidalCPseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary diseaseRespiration2012841364321996555
  • Martínez-SolanoLMaciaMDFajardoAOliverAMartinezJLChronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary diseaseClin Infect Dis200847121526153318990062